These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 7533774

  • 1. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
    Grinspoon S, Clemmons D, Swearingen B, Klibanski A.
    J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 5. Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly.
    Ezzat S, Ren SG, Braunstein GD, Melmed S.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):441-3. PubMed ID: 1713220
    [Abstract] [Full Text] [Related]

  • 6. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC, Rossi A, Martinelli CE, Machado HR, Moreira AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ, Kwon SH, Kim SW, Park DJ, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2001 Jul; 56(3-4):117-23. PubMed ID: 11847474
    [Abstract] [Full Text] [Related]

  • 8. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N.
    Exp Clin Endocrinol Diabetes; 1998 Apr; 106(2):130-4. PubMed ID: 9628244
    [Abstract] [Full Text] [Related]

  • 10. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR.
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [Abstract] [Full Text] [Related]

  • 11. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

  • 12. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE.
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [Abstract] [Full Text] [Related]

  • 13. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
    Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
    [Abstract] [Full Text] [Related]

  • 14. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A, Mendoza V.
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [Abstract] [Full Text] [Related]

  • 15. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A, Brismar K, Degerblad M, Thorén M, Hall K.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [Abstract] [Full Text] [Related]

  • 16. Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis.
    van der Lely AJ, de Herder WW, Janssen JA, Lamberts SW.
    J Endocrinol; 1997 Oct; 155 Suppl 1():S9-13; discussion S15-6. PubMed ID: 9389990
    [Abstract] [Full Text] [Related]

  • 17. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 18. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Fukuda I, Hizuka N, Itoh E, Yasumoto K, Ishikawa Y, Murakami Y, Sata A, Takano K.
    Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
    [Abstract] [Full Text] [Related]

  • 19. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP, Zini M, Quin JD, Jones J, Portioli I, Valcavi R.
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
    Wass JA.
    J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.